1-1 of 1
Eriko Isshiki
Close
Sort by
Journal Articles

Gilteritinib (ASP2215), a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Combination with Azacitidine in Acute Myeloid Leukemia

Yoko Ueno, PhD, Masamichi Mori, MSc, Yoshiteru Kamiyama, PhD, Naoki Kaneko, PhD, Eriko Isshiki, Masahiro Takeuchi, PhD
Journal: Blood
Blood (2016) 128 (22): 2830.
https://doi.org/10.1182/blood.V128.22.2830.2830
Published: 2016